The Innate Pulmonary Granuloma: Characterization and Demonstration of Dendritic Cell Recruitment and Function

American Journal of Pathology

Volumn 164, Issue 3, 2004, Pages 1021-1030

  Chiu, Bo Chin ^a   Freeman, Christine M ^a   Stolberg, Valerie R ^b   Hu, Jerry S ^a   Komuniecki, Eric ^a   Chensue, Stephen W ^a,b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Ann Arbor Veteran Administration Health Center   (United States)

^c VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE; CHEMOKINE CCL22; CHEMOKINE CCL4; CHEMOKINE CXCL2; CXCL9 CHEMOKINE; CYTOKINE; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN P 15095; INTERLEUKIN 1; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; PARASITE ANTIGEN; SOLUBLE EGG ANTIGEN; T LYMPHOCYTE ANTIGEN; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TUBERCULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; ELECTRON MICROSCOPY; FEMALE; FLOW CYTOMETRY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LUNG GRANULOMA; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; TH1 CELL; TH2 CELL;

EID: 1242316258     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63189-6     Document Type: Article

References (40)

1. Basset C, Holton J, O'Mahony R, Roitt I: Innate immunity and pathogen-host interaction. Vaccine 2003, 21:S12-S23
2. Beutler B: Science review: key inflammatory and stress pathways in critical illness-the central role of the Toll-like receptors. Crit Care 2003, 7:39-46
3. Koga T, Duan H, Urabe K, Furue M: Immunohistochemical localization of activated and mature CD83+ dendritic cells in granulomas of sporotrichosis. Eur J Dermatol 2001, 11:527-529
4. Iyonaga K, McCarthy KM, Schneeberger EE: Dendritic cells and the regulation of a granulomatous immune response in the lung. Am J Respir Cell Mol Biol 2002, 26:671-679
5. Uehira K, Amakawa R, Ito T, Tajima K, Naitoh S, Ozaki Y, Shimizu T, Yamaguchi K, Uemura Y, Kitajima H, Yonezu S, Fukuhara S: Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 2002, 105:296-303
6. Tsuchiya T, Chida K, Suda T, Schneeberger EE, Nakamura H: Dendritic cell involvement in pulmonary granuloma formation elicited by bacillus Calmette-Guerin in rats. Am J Respir Crit Care Med 2002, 165:1640-1646
7. Pagliari C, Sotto MN: Dendritic cells and pattern of cytokines in paracoccidioidomycosis skin lesions. Am J Dermatopathol 2003, 25:107-112
8. Clark GJ, Angel N, Kato M, Lopez JA, MacDonald K, Vuckovic S, Hart DN: The role of dendritic cells in the innate immune system. Microbes Infect 2000, 2:257-272
9. Medzhitov R: Toll-like receptors and innate immunity. Nat Rev Immunol 2001, 1:135-145
10. Chensue SW, Warmington KS, Ruth JH, Lincoln P, Kunkel SL: Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF. J Immunol 1995, 154:5969-5976
11. Ruth JH, Warmington KS, Shang X, Lincoln P, Evanoff H, Kunkel SL, Chensue SW: Interleukin-4 and -13 participation in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation: multiparameter analysis of cellular recruitment, chemokine expression and cytokine networks. Cytokine 2000, 12:432-444
12. Qiu B, Frait KA, Reich F, Komuniecki E, Chensue SW: Chemokine expression dynamics in mycobacterial (type-1) and schistosomal (type-2) antigen-elicited pulmonary granuloma formation. Am J Pathol 2001, 158:1503-1515
13. Vella AT, Pearce EJ: CD4+ Th2 response induced by Schistosoma mansoni eggs develops rapidly, through an early, transient, Th0-like stage. J Immunol 1992, 148:2283-2290
14. Holt PG, Stumbles PA, McWilliam AS: Functional studies on dendritic cells in the respiratory tract and related mucosal tissues. J Leukoc Biol 1999, 66:272-275
15. Stumbles PA, Thomas JA, Pimm CL, Lee PT, Venaille TJ, Proksch S, Holt PG: Resting respiratory tract dendritic cells preferentially stimulate T helper cell type 2 (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity. J Exp Med 1998, 188:2019-2031
16. Constant SL, Brogdon JL, Piggott DA, Herrick CA, Visintin I, Ruddle NH, Bottomly K: Resident lung antigen-presenting cells have the capacity to promote Th2 T cell differentiation in situ. J Clin Invest 2002, 110:1441-1448
17. Chiu BC, Shang XZ, Stolberg VR, Komuniecki E, Chensue SW: Population analysis of CD4+ T cell chemokine receptor transcript expression during in vivo type-1 (mycobacterial) and type-2 (schistosomal) immune responses. J Leukoc Biol 2002, 72:363-372
18. Chiu BC, Freeman CM, Stolberg VR, Komuniecki E, Lincoln PM, Kunkel SL, Chensue SW: Cytokine-chemokine networks in experimental mycobacterial and schistosomal lung granuloma formation. Am J Respir Cell Mol Biol 2003, 10:106-116
19. Chensue SW, Warmington K, Ruth JH, Lukacs N, Kunkel SL: Mycobacterial and schistosomal antigen-elicited granuloma formation in IFN-gamma and IL-4 knockout mice: analysis of local and regional cytokine and chemokine networks. J Immunol 1997, 159:3565-3573
20. Julia V, Hessel EM, Malherbe L, Glaichenhaus N, O'Garra A, Coffman RL: A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity 2002, 16:271-283
21. Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 2003, 3:133-146
22. Sallusto F, Palermo B, Lenig D, Miettinen M, Matikainen S, Julkunen I, Forster R, Burgstahler R, Lipp M, Lanzavecchia A: Distinct patterns and kinetics of chemokine production regulate dendritic cell function. Eur J Immunol 1999, 29:1617-1625
23. Guermonprez P, Valladeau J, Zitvogel L, Thery C, Amigorena S: Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol 2002, 20:621-667
24. Boros DL: Granulomatous inflammations. Prog Allergy 1978, 24:183-267
25. Cocito C, Vanlinden F: Preparation and properties of antigen 60 from Mycobacterium bovis BCG. Clin Exp Immunol 1986, 66:262-272
26. Muzio M, Mantovani A: Toll-like receptors. Microbes Infect 2000, 2:251-255
27. Chiu BC, Chensue SW: Chemokine responses in schistosomal antigen-elicited granuloma formation. Parasite Immunol 2002, 24:285-294
28. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ: Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999, 163:3920-3927
29. Abel B, Thieblemont N, Quesniaux VJ, Brown N, Mpagi J, Miyake K, Bihl F, Ryffel B: Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002, 169:3155-3162
30. Peters W, Dupuis M, Charo IF: A mechanism for the impaired IFN-gamma production in C-C chemokine receptor 2 (CCR2) knockout mice: role of CCR2 in linking the innate and adaptive immune responses. J Immunol 2000, 165:7072-7077
31. Peters W, Scott HM, Chambers HF, Flynn JL, Charo IF, Ernst JD: Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2001, 98:7958-7963
32. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, Medzhitov R: Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001, 2:947-950
33. van der Kleij D, Latz E, Brouwers JF, Kruize YC, Schmitz M, Kurt-Jones EA, Espevik T, de Jong EC, Kapsenberg ML, Golenbock DT, Tielens AG, Yazdanbakhsh M: A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization. J Biol Chem 2002, 277:48122-48129
34. MacDonald AS, Straw AD, Bauman B, Pearce EJ: CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001, 167:1982-1988
35. Constant SL: B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 1999, 162:5695-5703
36. Linton PJ, Bautista B, Biederman E, Bradley ES, Harbertson J, Kondrack RM, Padrick RC, Bradley LM: Costimulation via OX40L expressed by B cells is sufficient to determine the extent of primary CD4 cell expansion and Th2 cytokine secretion in vivo. J Exp Med 2003, 197:875-883
37. Koch AE, Kunkel SL, Chensue SW, Haines GK, Strieter RM: Expression of interleukin-1 and interleukin-1 receptor antagonist by human rheumatoid synovial tissue macrophages. Clin Immunol Immunopathol 1992, 65:23-29
38. Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA: Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453
39. Schulz O, Edwards AD, Schito M, Aliberti J, Manickasingham S, Sher A, Reis e Sousa C: CD40 triggering of heterodimeric IL-12 p70 production by dendritic cells in vivo requires a microbial priming signal. Immunity 2000, 13:453-462
40. Szabo SJ, Sullivan BM, Peng SL, Glimcher LH: Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 2003, 21:713-758